(
Entos Pharmaceuticals) Entos is developing Covigenix; a pan-coronavirus Fusogenix DNA vaccine to address COVID-19 and future threats. Entos has partnered with Precision NanoSystems to incorporate their NanoAssemblr GMP System into a highly scalable manufacturing workflow to produce vaccines and genetic nanomedicines.
